Search Results
Results found for "Larry Barak"
Posts (34)
- When the Assay Says Nothing, Look Again: Kinetic Detection of Multi-Target GPCR Activity
The Steady-State Cancellation Problem A scaffold carrying both agonist and antagonist activity presents The peptide sequence carries a region responsible for efficacy and a separate region that functions as When a scaffold carries both activities, kinetic assays produce complex time-dependent response curves A scaffold that reads as inactive under standard screening conditions may carry multiple activities that
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
And that’s exactly what carries strong discovery programs into 2026. GPCR Year in Review: Carrying Better Experiments Into 2026 As 2025 closes, the Dr.
- Four Reasons to Measure GPCR Signaling Bias in Drug Discovery
Morphine provides effective analgesia but carries debilitating side effects including respiratory depression The κ-opioid receptor illustrates this directly. κ-Opioid agonists carry genuine therapeutic potential across G protein, β-arrestin, and second messenger pathways through cell-based assay assessments — carry
Other Pages (25)
- Dr. Caron Tribute Part 2 | Dr. GPCR Ecosystem
Larry Barak (1994) Dr. Kathleen Caron - Co-host- (1970) Dr. Steve Ferguson (1995) Dr.
- Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
Gutkind — carrying a personal loss in New York and leading a cancer center building that operated at Because trainees rotate through multiple labs, they carry science from one bench to another. Dr. "These rotation students are like cross-pollination… almost like the sorting hat in Harry Potter."
- Qing Fan: Inside the Architecture of Class C GPCRs | Dr. GPCR Ecosystem
orthosteric ligands within their transmembrane domain and can function as monomers, class C receptors carry - what it enabled and what it still cannot resolve KEY INSIGHTS FROM THE CONVERSATION Class C GPCRs carry Dimerization is not optional - it is the mechanism GABA-B is an obligate heterodimer: the GABA-B1 subunit carries It is used to treat muscle spasticity in multiple sclerosis and spinal cord injury, but it carries significant






